Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Albumin Use Guidelines and Outcome in a Surgical Intensive Care Unit

Albumin Use Guidelines and Outcome in a Surgical Intensive Care Unit ORIGINAL ARTICLE Albumin Use Guidelines and Outcome in a Surgical Intensive Care Unit Anthony Charles, MD; Maryanne Purtill, MD; Sharon Dickinson, RN, MSN, CCRN; Michael Kraft, PharmD; Melissa Pleva, PharmD; Craig Meldrum, BBA; Lena Napolitano, MD Hypothesis: Restrictive albumin use guidelines in the costs were obtained from the pharmacy prospective surgical intensive care unit (SICU) will not increase mor- database. tality and will result in cost savings. Results: A total of 1361 patients were included in the study. A statistically significant reduction in albumin use (54%) Design: Prospective cohort study. was found in the fourth quarter (P=.004), and a substan- Setting: Tertiary teaching hospital. tial cost saving was realized (56% reduction in cost) with the albumin use guidelines. Restrictive use of albumin had Patients: All patients admitted to the SICU from July no negative impact on ICU mortality. Mean Acute Physi- 1, 2004, through July 1, 2005, were included in this ology and Chronic Health Evaluation III scores on ICU day study. 1 were not different. No significant difference in mean ICU length of stay was noted. Maintained reduction in the use Interventions: Patients in the first 3 quarters of the study of albumin was documented during the next http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Surgery American Medical Association

Albumin Use Guidelines and Outcome in a Surgical Intensive Care Unit

Download PDF
5 pages

Loading next page...
 
/lp/american-medical-association/albumin-use-guidelines-and-outcome-in-a-surgical-intensive-care-unit-dAXB0BPlGe

References (43)

Publisher
American Medical Association
Copyright
Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6254
eISSN
2168-6262
DOI
10.1001/archsurg.143.10.935
pmid
18936370
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Albumin Use Guidelines and Outcome in a Surgical Intensive Care Unit Anthony Charles, MD; Maryanne Purtill, MD; Sharon Dickinson, RN, MSN, CCRN; Michael Kraft, PharmD; Melissa Pleva, PharmD; Craig Meldrum, BBA; Lena Napolitano, MD Hypothesis: Restrictive albumin use guidelines in the costs were obtained from the pharmacy prospective surgical intensive care unit (SICU) will not increase mor- database. tality and will result in cost savings. Results: A total of 1361 patients were included in the study. A statistically significant reduction in albumin use (54%) Design: Prospective cohort study. was found in the fourth quarter (P=.004), and a substan- Setting: Tertiary teaching hospital. tial cost saving was realized (56% reduction in cost) with the albumin use guidelines. Restrictive use of albumin had Patients: All patients admitted to the SICU from July no negative impact on ICU mortality. Mean Acute Physi- 1, 2004, through July 1, 2005, were included in this ology and Chronic Health Evaluation III scores on ICU day study. 1 were not different. No significant difference in mean ICU length of stay was noted. Maintained reduction in the use Interventions: Patients in the first 3 quarters of the study of albumin was documented during the next

Journal

JAMA Surgery – American Medical Association

Published: Oct 1, 2008

There are no references for this article.